About this Research Topic
New variants are evolving in SARS-CoV-2, and RBD mutations are associated with enhanced infectivity, greater transmissibility, and a higher capacity to evade/escape from neutralizing antibodies. COVID-19 vaccine or natural infection can educate the immunity, but it still unknown whether antibodies transferred to neonates will protect against the SARS-CoV-2 mutations from variants of concern. Lastly, investigations are required to identify the maternal factors (including genetics, nutrition, preexisting immunity, and health conditions) that enhance the immune responses against pediatric infectious diseases.
This Research Topic will focus on Breast Milk and Passive Immunity during the COVID-19 Pandemic. Authors can submit original research, review, mini review, commentary, and opinion articles focused on but not limited to:
(1) COVID-19 vaccine and immune responses in breast milk;
(2) natural infection and vaccination of COVID-19 in mother-infant immunity;
(3) neutralizing antibodies against SARS-CoV-2 from variants of concern in breast milk; and
(4) maternal factors improving passive immunity during COVID-19.
VDM is an employee at Medolac Laboratories. LB and HVG have no conflict of interest to disclose.
Keywords: breastfeeding, breast milk, SARS-CoV-2, infant feeding, passive immunity, antibody
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.